
Kineta to Present at the Oppenheimer 33rd Annual Healthcare Conference
SEATTLE, March 08, 2023 -- Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on the development of novel immunotherapies in oncology that address cancer immune resist ...